|
|
 |
|
Viewing report
|
|
|
|
Cough and Cold Preparations Market in Venezuela to 2014 (OTC Healthcare)
Datamonitor, Feb 2011, Pages: 29
Introduction
This databook provides key data and information on the Cough and Cold Preparations Market in Venezuela (OTC Healthcare). This report is a comprehensive resource for market, category and segment level data including value, volume, distribution share and company & brand share. This report also provides expenditure and consumption data for the historic and forecast periods.
Scope
-Market,category and segment level information on value, volume, and expenditure & consumption, with historic (2003-2008) and forecast (2009-2013) data
-Category level company and brand share as well as distribution share information for 2007 and 2008
Highlights
The cough and cold preparations category was valued at VEF189,517.6m ($88.3m) in 2009, representing a CAGR of 9.9% since 2004.
By the end of 2014, the cough and cold preparations category will be worth VEF251,398m ($117.2m), with an expected CAGR of 5.8% between 2009 and 2014.
The cough and cold preparations market was led by tablets (representing 49.7% of the total value) followed by lozenges and mixtures, with a 24.8% and 10.8% market share, respectively. Topical remedies and inhalers constitute the remaining segments with an 8% and 6.8% market share, respectively.
GlaxoSmithKline Plc is the market leader with a 30.9% share of the market.
Reasons to Purchase
-Develop business strategies by understanding the quantitative trends within the Cough and Cold Preparations Market in Venezuela (OTC Healthcare)
-Design effective marketing and sales strategies by identifying key market categories and segments
-Identify key players within the market to plan lucrative M&A, partnerships and agreements
|
|
|
|
